⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL363759 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL380580 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL1360048 | 0.92 | — | — | |
| Acetic Acid SCHEMBL28554233 | 0.89 | GAA (0.48) | — | |
| SCHEMBL5349106 | 0.79 | RECQL (0.61) | — | |
| Butyric Acid SCHEMBL28166159 | 0.79 | FFAR3 (0.54) | — | |
| SCHEMBL124341 | 0.79 | ALDH1A1 (0.41) | — | |
| SCHEMBL28528228 | 0.78 | GAA (0.48) | — | |
| SCHEMBL17837031 | 0.78 | — | — | |
| SCHEMBL19380638 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3056509-A1 | BOMBESIN ANALOGUES FOR USE IN DIAGNOSIS | Piramal Imaging SA (CH) | 2016-08-17 | — | — | EP | disclosed |
| EP-2063918-B1 | COMPOUNDS AND METHODS FOR 18F LABELED AGENTS | PIRAMAL IMAGING SA (CH) | 2014-02-26 | — | — | EP | disclosed |
| US-8557776-B2 | Compounds and methods for 18F labeled agents | Bayer Pharma AG (DE) | 2013-10-15 | — | — | US | disclosed |
| EP-2455105-A2 | Bombesin analogues | Bayer Pharma Aktiengesellschaft (DE) | 2012-05-23 | — | — | EP | disclosed |
| EP-2289564-A2 | Derivatives of aniline as precursors for F18-labeling | Bayer Schering Pharma Aktiengesellschaft (DE) | 2011-03-02 | — | — | EP | disclosed |
| EP-2279759-A2 | Compounds and methods for 18F labeled agents | Bayer Schering Pharma Aktiengesellschaft (DE) | 2011-02-02 | — | — | EP | disclosed |
| EP-2063918-A2 | COMPOUNDS AND METHODS FOR 18F LABELED AGENTS | Bayer Schering Pharma AG (DE) | 2009-06-03 | — | — | EP | disclosed |
| US-20080292548-A1 | COMPOUNDS AND METHODS FOR 18F LABELED AGENTS | Lantheus Biosciences Ltd. (GB) | 2008-11-27 | — | — | US | disclosed |
| WO-2008028688-A2 | COMPOUNDS AND METHODS FOR 18F LABELED AGENTS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-03-13 | — | — | WO | disclosed |
| EP-1897885-A1 | Compounds and methods for F labelled agents | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-03-12 | — | — | EP | disclosed |